Agios Pharmaceuticals, Inc.
AGIO
$28.42
$0.431.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.90% | 55.02% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.90% | 55.02% | |||
| Cost of Revenue | -8.30% | 1.65% | |||
| Gross Profit | 11.79% | 7.44% | |||
| SG&A Expenses | -6.41% | 25.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.61% | 9.09% | |||
| Operating Income | 9.50% | -4.03% | |||
| Income Before Tax | 9.12% | -5.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.26% | -4.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.26% | -4.45% | |||
| EBIT | 9.50% | -4.03% | |||
| EBITDA | 9.68% | -4.17% | |||
| EPS Basic | 8.94% | -4.08% | |||
| Normalized Basic EPS | 9.79% | -5.05% | |||
| EPS Diluted | 8.94% | -4.02% | |||
| Normalized Diluted EPS | 9.79% | -5.05% | |||
| Average Basic Shares Outstanding | 0.74% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.74% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||